| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/18/2010 | US20100041751 Method to Reduce Oxidative Damage and Improve Mitochondrial Efficiency |
| 02/18/2010 | US20100041749 Organo-Arsenoxide Compounds and Use Thereof |
| 02/18/2010 | US20100041748 Fatty acid acetylated salicylates and their uses |
| 02/18/2010 | US20100041747 Use of certain chemical compounds for the inhibition of the peptidyl-prolyl cis/trans isomerase activity of cyclophilins |
| 02/18/2010 | US20100041746 Novel use of organic compounds |
| 02/18/2010 | US20100041745 Aigialomycin D and Derivatives Thereof and Their Use in Treating Cancer or Malaria or a Microbial Infection |
| 02/18/2010 | US20100041744 Oily paclitaxel composition and formulation for chemoembolization and preparation method thereof |
| 02/18/2010 | US20100041742 Riboswitches, methods for their use, and compositions for use with riboswitches |
| 02/18/2010 | US20100041741 Suppression of mitochondrial oxidative stress |
| 02/18/2010 | US20100041740 Flu vaccines and methods of use thereof |
| 02/18/2010 | US20100041738 Hybridization-stabilizing construct |
| 02/18/2010 | US20100041737 Gene Vector |
| 02/18/2010 | US20100041736 Isolated MCPIP and Methods of Use |
| 02/18/2010 | US20100041735 Modulation of toll-like receptor 3 expression by antisense oligonucleotides |
| 02/18/2010 | US20100041734 Modulation of toll-like receptor 7 expression by antisense oligonucleotides |
| 02/18/2010 | US20100041733 NOVEL RNAi THERAPEUTIC FOR TREATMENT OF HEPATITIS C INFECTION |
| 02/18/2010 | US20100041732 Methods for identifying compounds that inhibit hiv infection |
| 02/18/2010 | US20100041731 Solid states of atorvastatin potassium |
| 02/18/2010 | US20100041730 Alkylated heterocyclic reaction products useful as antioxidants |
| 02/18/2010 | US20100041729 Dithiolopyrrolones compounds and their therapeutic applications |
| 02/18/2010 | US20100041728 Hcv inhibiting macrocyclic phenylcarbamates |
| 02/18/2010 | US20100041726 INHIBITORS OF Akt ACTIVITY |
| 02/18/2010 | US20100041725 Stable pharmaceutical composition |
| 02/18/2010 | US20100041724 such as anacetrapib; cholesterol ester transfer protein inhibitors (CETP); atherosclerosis |
| 02/18/2010 | US20100041723 Thiazole Compound (as PPAR delta) Ligand and Pharmaceutical, Cosmetic and Health Food Comprised Thereof |
| 02/18/2010 | US20100041722 Organic compounds |
| 02/18/2010 | US20100041721 Selective androgen receptor modulators |
| 02/18/2010 | US20100041720 Novel compounds as cannabinoid receptor ligands |
| 02/18/2010 | US20100041719 Mitotic kinesin inhibitors and methods of use thereof |
| 02/18/2010 | US20100041717 N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases |
| 02/18/2010 | US20100041716 Nitroxides for use in treating or preventing hypercholesterolemia |
| 02/18/2010 | US20100041715 Sphingosine-1-phosphate (s1p) receptor antagonists and methods for use thereof |
| 02/18/2010 | US20100041714 Bi-aryl aminotetralines |
| 02/18/2010 | US20100041713 Substituted aminotetralines |
| 02/18/2010 | US20100041712 Substituted imidazole combinations |
| 02/18/2010 | US20100041711 Urea Glucokinase Activators |
| 02/18/2010 | US20100041709 Substituted n-(4-cyano-1h-pyrazol-3-yl)methylamine derivatives, preparation thereof and therapeutic use thereof |
| 02/18/2010 | US20100041708 N-phenylarylsulfonamide compound, pharmaceutical composition comprising the compound as active ingredient, synthetic intermediate for the compound and process for it's preparation |
| 02/18/2010 | US20100041707 Inhibitors of ion channels |
| 02/18/2010 | US20100041706 Compounds 501 |
| 02/18/2010 | US20100041705 Organic Compounds |
| 02/18/2010 | US20100041704 Dermal compositions of substituted amides and the use thereof as medication for pain and pruritus |
| 02/18/2010 | US20100041703 Rapid disintegration monolayer film for the oral administration of active substances |
| 02/18/2010 | US20100041702 Benzimidazole cannabinoid agonists |
| 02/18/2010 | US20100041701 Biphenyl compounds useful as muscarinic receptor antagonists |
| 02/18/2010 | US20100041699 Microcrystalline (5-fluoro-2-methyl-3-quinolin-2-ylmethyl-indol-1-yl) acetic acid |
| 02/18/2010 | US20100041698 Heterocyclic compounds and their use as binding partners for 5-ht5 receptors |
| 02/18/2010 | US20100041697 Pneumonia treatment |
| 02/18/2010 | US20100041696 Compounds |
| 02/18/2010 | US20100041695 Thieno[2,3-b]pyridines as Potassium Channel Inhibitors |
| 02/18/2010 | US20100041693 Indolylmaleimide derivatives |
| 02/18/2010 | US20100041692 Pyrrolo[4,3,2-de]quinolin-8-amine compounds and methods of their preparation and use |
| 02/18/2010 | US20100041691 Pharmaceutical compositions comprising combinations of an ampa/kainate antagonistic compound and an inhibitor of a multidrug resistance protein |
| 02/18/2010 | US20100041690 Co-Administration of Dopamine-Receptor Binding Compounds |
| 02/18/2010 | US20100041689 Combined Effects of Topiramate and Ondansetron on Alcohol Consumption |
| 02/18/2010 | US20100041688 Revaprazan-containing solid dispersion and process for the preparation thereof |
| 02/18/2010 | US20100041687 Hydrobromide salt of an anti-hiv compound |
| 02/18/2010 | US20100041686 4,5-dihydro-oxazol-2yl derivatives |
| 02/18/2010 | US20100041685 Stat3 inhibitors |
| 02/18/2010 | US20100041684 Pyrimidyl derivatives as protein kinase inhibitors |
| 02/18/2010 | US20100041683 Novel chain-breaking antioxidants |
| 02/18/2010 | US20100041681 2-amino pyrimidine compounds as potent hsp-90 inhibitors |
| 02/18/2010 | US20100041680 Piperidine derivatives |
| 02/18/2010 | US20100041679 Oral dieting composition comprising conjugated linoleic acid and caffeine |
| 02/18/2010 | US20100041678 Compositions and methods for treating inflammatory disorders |
| 02/18/2010 | US20100041677 Inhibitors of bruton's tyrosine kinase |
| 02/18/2010 | US20100041676 Kinase inhibitors |
| 02/18/2010 | US20100041675 treatment of retinopathy comprising administering drugs such as tert-butyl 3-[5-ethyl-6-[4-(5,6,7,8-tetrahydro-(1,8)naphthyridin-2-yl)-piperidin-1-yl]-pyrimidin-4-ylamino]-2-(4-methoxy benzoyl)-propionate |
| 02/18/2010 | US20100041674 Hcv protease inhibitors and uses thereof |
| 02/18/2010 | US20100041673 5-(heterocyclyl)alkyl-n-(arylsulfonyl)indole compounds and their use as 5-ht6 ligands |
| 02/18/2010 | US20100041672 Use of quinoline derivatives in the treatment of pain and irritable bowel syndrome |
| 02/18/2010 | US20100041671 Methods for treating glaucoma |
| 02/18/2010 | US20100041670 monoacyl glycerol lipase and fatty acid amide hydrolase inhibitors such as [5-(2-chlorophenyl)[1,2,3]triazolo[4,5-b]pyridin-3-yl][4-(3-trifluoromethylphenyl) piperazin-1-yl]methanone, used as analgesics or for the treatment of vomiting and nausea |
| 02/18/2010 | US20100041669 4-(heterocyclyl)alkyl-n-(arylsulfonyl)indole compounds and their use as 5-ht6 ligands |
| 02/18/2010 | US20100041668 Compositions and methods for treating thrombocytopenia |
| 02/18/2010 | US20100041667 Piperidine and pyrrolidine beta-secretase inhibitors for the treatment of alzheimer's disease |
| 02/18/2010 | US20100041666 Use of N-Phenyl-2-pyrimidineamine Derivativea Against Mast Cell-based Diseases Like Allergic Disorders |
| 02/18/2010 | US20100041665 N-phenyl-prenylamine derivatives for the treatment of cognitive, neurodegenerative or neuronal diseases or disorders |
| 02/18/2010 | US20100041664 Bicyclic lactam factor viia inhibitors useful as anticoagulants |
| 02/18/2010 | US20100041663 Organic Compounds as Smo Inhibitors |
| 02/18/2010 | US20100041662 Heterocyclic compounds as antiinflammatory agents |
| 02/18/2010 | US20100041660 Novel 2-pyridinecarboxamide derivatives |
| 02/18/2010 | US20100041658 Hydroxyphenyl Derivatives and Biological Applications Thereof |
| 02/18/2010 | US20100041657 Haloalkylsulfone substituted compounds useful for treating obesity and diabetes |
| 02/18/2010 | US20100041656 Novel amide derivatives and medicinal use thereof |
| 02/18/2010 | US20100041655 Triazole derivative |
| 02/18/2010 | US20100041654 Pyrimidine Derivatives And Their Use As CB2 Modulators |
| 02/18/2010 | US20100041653 Composition and methods for the design and development of metallo-enzyme inhibitors |
| 02/18/2010 | US20100041652 Tyrosine kinase inhibitors |
| 02/18/2010 | US20100041651 Triazolopyridine carboxamide derivatives and triazolopyrimidine carboxamide derivatives, preparation thereof and therapeutic use thereof |
| 02/18/2010 | US20100041650 Purine compounds as cannabinoid receptor blockers |
| 02/18/2010 | US20100041649 viricides used for for treating a human papillomavirus (HPV) viral infections, for inhibiting HPV DNA replication or for preventing prenatal transmission of HPV from mother to baby by administering to the mother prior to giving birth |
| 02/18/2010 | US20100041648 Methods for treating retroviral infections |
| 02/18/2010 | US20100041647 3-Substituted-[1,2,3]-Benzotriazinone compounds for enhancing glutamatergic synaptic responses |
| 02/18/2010 | US20100041646 Phenylene-Bis-Oxazolidine Derivatives and Their Use as Anticoagulants |
| 02/18/2010 | US20100041645 Rho kinase inhibitors |
| 02/18/2010 | US20100041644 Stabilized solid pharmaceutical composition of candesartan cilexetil |
| 02/18/2010 | US20100041643 Thienotriazolodiazepine compound and medicinal use thereof |
| 02/18/2010 | US20100041642 Urea inhibitors of map kinases |
| 02/18/2010 | US20100041641 Uses of metabotropic glutamate receptors |